000 01704nam##2200265za#4500
0019.688789
003CaOODSP
00520220107103655
007cr |||||||||||
008150407|2006||||xxc|||||o    f|0| 0 eng|d
020 |a0-662-43991-0
040 |aCaOODSP|beng
043 |an-cn---
0861 |aHP40-4/1-2006E-PDF
1102 |aCentre for Infectious Disease Prevention and Control (Canada)
24510|aI Track - enhanced surveillance of risk behaviours among injecting drug users in Canada : |h[electronic resource]|bPhase I report / |cpresented by the Surveillance and Risk Assessment Division.
260 |aOttawa - Ontario : |bPublic Health Agency of Canada. |c©2006.
300 |a107p.|breferences, tables
5203 |aThis report presents statistics from Phase I of I-Track, an enhanced surveillance system to track risk behaviours associated with HIV and hepatitis C virus (HCV) among injecting drug users (IDUs). It aims to describe changing patterns in drug injecting practices, HIV- and HCV-testing behaviours, and sexual behaviours among IDUs. Tables present data on recruitment, prevalence of HIV and HCV, drug use and other behaviours, and demographics of the study population.
590 |a08-04|b2008-01-25
69007|aDrug use|2gcpds
69007|aControl|2gcpds
77508|tI Track - Surveillance améliorée des comportements à risque chez les utilisateurs de drogues injectables au Canada : |w(CaOODSP)9.633208
7760#|tI Track - enhanced surveillance of risk behaviours among injecting drug users in Canada : |w(CaOODSP)9.650294
85640|ahttp://publications.gc.ca|qPDF|s952 KB|uhttps://publications.gc.ca/collections/collection_2008/phac-aspc/HP40-4-1-2006E.pdf